跳至主要内容
临床试验/IRCT20201225049827N1
IRCT20201225049827N1招募中3 期

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin–A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder, Randomized Clinical Trial Study

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 84 years(—)
性别
Male

入选标准

  • Obstructive symptoms of urinary obstruction defined by IPSS and enlarged prostate on DRE examination
  • Consent to enter the study
  • Existence of LUTS symptoms
  • OAB and DO approval with biodynamics and Eurodynamics study

排除标准

  • Patients with neurological diseases such as Parkinson's or stroke
  • Prostate or bladder cancer
  • People who have had bladder or prostate surgery in the past
  • Dissatisfaction with enrollment
  • Allergy to sulifenacin or Botox

研究者

相似试验

Clinical Efficacy of Transurethral Resection of the... | 临床试验